Appointment booking for Dr. Michael Judice, MD is currently not available.Dr. Michael Judice, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Michael Judice, MD (he/him) is a Pediatrician in Lafayette, LA with over 17 years of experience. What is your opinion of Dr. Michael Judice, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Judice, MD has received over $2,160 which includes payments from the following companies:
$495.93 from Shire North American Group Inc
$278.62 from Pfizer Inc.
$256.41 from Sanofi Pasteur Inc.
$254.55 from Rhodes Pharmaceuticals L.P.
$147.90 from Neos Therapeutics, LP
$114.96 from Arbor Pharmaceuticals, Inc.
$97.54 from Meda Pharmaceuticals, Inc.
$97.31 from Tris Pharma Inc
$95.40 from FSC Laboratories, Inc.
$41.87 from Kaleo, Inc.
$37.19 from GlaxoSmithKline, LLC.
$32.65 from Adlon Therapeutics L.P.
$30.81 from Mylan Specialty L.P.
$24.46 from Lupin Pharmaceuticals, Inc
$21.61 from Merck Sharp & Dohme Corporation
$20.09 from MedImmune, LLC
$19.39 from Aerocrine, Inc
$16.75 from Alcon Laboratories Inc
$15.42 from Ironshore Pharmaceuticals Inc.
$14.58 from Bausch and Lomb Inc.
Payments received by Dr. Michael Judice, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!